title: Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard.
authors.affiliation: 1 Department of Radiation Oncology, Ege University, School of Medicine, Izmir, Turkey ; 2 Department of Radiation Oncology, Koç University, School of Medicine, Istanbul, Turkey ; 3 Department of Radiation Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Deniz
authors.initials: D
authors.lastname: Yalman
authors.affiliation: 1 Department of Radiation Oncology, Ege University, School of Medicine, Izmir, Turkey ; 2 Department of Radiation Oncology, Koç University, School of Medicine, Istanbul, Turkey ; 3 Department of Radiation Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Ugur
authors.initials: U
authors.lastname: Selek